> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fed Reg Notice on Pemoline Corrected
- URL: https://www.fdaweb.com/fed-reg-notice-on-pemoline-corrected/
- Published: 2019-10-03T12:00:00.000Z
- Updated: 2026-09-15T01:54:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145163

*Federal Register* notice: FDA has corrected a 6/4 *Federal* Register notice withdrawing approval of five ANDAs for pemoline products because it contained an incorrect Web site address for an archived Web page of a Postmarket Drug Safety Information for Healthcare Professionals communication that the agency issued 10/2005\. That communication concluded that the overall liver toxicity risk of Cylert and generic pemoline products outweighed the benefits of these products. The incorrect Web address has now been corrected. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21526.pdf?ref=fdaweb.com).